Targeting autophagy with SAR405 alleviates doxorubicin-induced cardiotoxicity
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting autophagy with SAR405 alleviates doxorubicin-induced cardiotoxicity
Authors
Keywords
-
Journal
CELL BIOLOGY AND TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-09-28
DOI
10.1007/s10565-023-09831-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pretreatment of 3-MA prevents doxorubicin-induced cardiotoxicity through inhibition of autophagy initiation
- (2023) Xiaofan Sun et al. TOXICOLOGY
- Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib
- (2021) Zhifei Xu et al. Autophagy
- atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
- (2021) Yong Wang et al. CIRCULATION RESEARCH
- Cardiac Autophagy Deficiency Attenuates ANP Production and Disrupts Myocardial-Adipose Crosstalk Leading to Increased Fat Accumulation and Metabolic Dysfunction
- (2020) Erfei Song et al. DIABETES
- Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy
- (2019) Michael P. Catanzaro et al. FASEB JOURNAL
- Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion
- (2018) Jun Gu et al. BIOCHEMICAL PHARMACOLOGY
- Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth
- (2018) Mingchuan Li et al. CIRCULATION
- Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Complications of Cancer Therapy
- (2017) Hui-Ming Chang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload–Induced Mitochondrial Dysfunction and Heart FailureCLINICAL PERSPECTIVE
- (2016) Akihiro Shirakabe et al. CIRCULATION
- Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome AcidificationCLINICAL PERSPECTIVE
- (2016) Dan L. Li et al. CIRCULATION
- Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity
- (2016) Jun Gu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
- (2016) Barbara L. Asselin et al. JOURNAL OF CLINICAL ONCOLOGY
- SAR405, a PIK3C3/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells
- (2015) Benoit Pasquier Autophagy
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy
- (2014) Guillermo Mariño et al. Autophagy
- A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy
- (2014) Baptiste Ronan et al. Nature Chemical Biology
- Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity
- (2013) P Vejpongsa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Resveratrol Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis in Lymphoma Nude Mice by Heme Oxygenase-1 Induction
- (2012) Jun Gu et al. Cardiovascular Toxicology
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium
- (2011) Lynda M. Vrooman et al. EUROPEAN JOURNAL OF CANCER
- Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer
- (2010) Kevin Dalby et al. Autophagy
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started